[ABCA1 gene expression in peripheral blood lymphocytes and macrophages in patients with atherosclerosis]

Insights

This study reveals reduced ABCA1 transporter mRNA in leukocytes but increased levels in macrophages of atherosclerosis patients. These findings suggest ABCA1 gene expression impacts atherosclerosis development.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • The ATP-binding cassette transporter A1 (ABCA1) is crucial for cholesterol efflux from peripheral tissues.
  • The precise role of ABCA1 in the pathogenesis of atherosclerosis requires further elucidation.

Purpose of the Study:

  • To investigate the expression levels of ABCA1 mRNA in leukocytes and macrophages of patients with atherosclerosis compared to healthy controls.
  • To determine the potential contribution of ABCA1 gene expression to atherosclerosis development.

Main Methods:

  • Real-Time quantitative Polymerase Chain Reaction (RT-PCR) was employed to measure ABCA1 mRNA levels.
  • Leukocytes and macrophages were isolated from patients diagnosed with atherosclerosis and from control individuals.

Main Results:

  • A statistically significant reduction in ABCA1 mRNA levels was observed in the leukocytes of atherosclerosis patients (0.57 +/- 0.28) compared to controls (0.93 +/- 0.14, p = 0.02).
  • Conversely, a significant increase in ABCA1 mRNA levels was detected in the macrophages of patients (1.32 +/- 0.10) relative to controls (0.90 +/- 0.14, p = 0.014).

Conclusions:

  • The differential expression of ABCA1 mRNA in leukocytes and macrophages suggests a complex role in atherosclerosis.
  • ABCA1 gene expression patterns may be a contributing factor in the development and progression of atherosclerosis.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...